Spencer Arrighetti, who recently returned from a broken thumb, becomes the latest in a long list of Houston starters to land ...

The Astros placed right-hander Spencer Arrighetti on the 15-day injured list because of inflammation in his right elbow ...

Shelby Miller says he's facing the possibility of a second Tommy John surgery as the Milwaukee Brewers placed the veteran ...

Brewers reliever Shelby Miller has a sprained right elbow and, most likely, is facing the second Tommy John surgery of his ...

By the time he met the media on Wednesday afternoon, Shelby Miller had already come to grips with the fact that his 2025 ...

A Houston Astros rotation finally nearing full strength sustained a substantial blow on Wednesday. The Astros placed ...

Shares of Vertex Pharmaceuticals sank 15% after the drugmaker announced a study showed its experimental pain medicine was not successful, and it would no longer move forward with its development.

Vertex drops aspiring Journavx follower in acute pain after phase 2 failure By Darren Incorvaia Aug 4, 2025 5:34pm Vertex Pharmaceuticals Clinical Trial Results pain failed trials ...

Based on these results, Vertex will not progress VX-993 into pivotal development as monotherapy in acute pain.

The Phase 2 study was a randomized, double-blind, placebo-controlled, dose-ranging study that evaluated three different doses of VX-993 administered orally in 367 patients with acute pain ...

Acute safety, cardiovascular, perceptual and neuromuscular responses to autoregulated and non-autoregulated blood flow restriction training during elbow rehabilitation in people with hemophilia ...

Yankees captain Aaron Judge, his teammates and New York’s fan base exhaled Saturday when the two-time AL MVP learned he has a flexor strain in his right elbow but no acute damage to his ulnar… ...